FDA issued a Warning Letter to Forest Laboratories, Inc. on 8/7/2003 for a previous inspection.
483 Allergan Sales Nov 2012

483 Allergan Sales Nov 2012

Christopher Middendorf FDA, Michael Sheehan FDA$119.00 - Available Now

FDA investigators audited the Allergan Sales - Cincinnati, OH, United States facility and issued 3 inspectional observations (via FDA 483) on 05 Nov 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 05 Nov 2012
  • Location: Cincinnati, United States
  • FEI: 1523957
Add To Cart